ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2312

Sociodemographic Characteristics and Healthcare Utilization in Patients with IBD-Associated Arthritis vs. IBD Alone: A Nationwide Inpatient Analysis

Faria Sami1, Maria I. ("Maio") Danila2, Liron Caplan3 and Rouhin Sen4, 1The University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham (UAB), Birmingham VA Medical Center, Birmingham, AL, 3Medicine Service, Rocky Mountain Regional VAMC, Aurora, CO, 4University of Alabama at Birmingham, Department of Medicine, Division of Clinical Immunology & Rheumatology, Birmingham

Meeting: ACR Convergence 2025

Keywords: Spondyloarthropathies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2305–2337) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Inflammatory bowel disease (IBD)-associated arthritis (IBD-A) can affect 24-44% of IBD patients and may represent an enhanced inflammatory state. IBD-A patients often experience a more severe disease course, increased hospitalizations, a higher need for surgical or biologic therapies, and worse outcomes compared to IBD alone. Prior studies have examined the reasons for hospitalizations for IBD, but the inpatient burden of IBD-A remains underexplored. Understanding differences in sociodemographic characteristics and healthcare utilization in patients with IBD-A vs IBD alone may help inform resource management and policy

Methods: We used the National Inpatient Sample (NIS) database to identify adult hospitalizations with a primary or secondary diagnosis of IBD from 2016 to 2020. Admissions with concurrent diagnosis of IBD-A were identified using ICD-10 codes. We compared demographics, insurance type, median household income, geographic location, length of stay (LOS), total hospital charges, and in-hospital mortality between patients with IBD-A and IBD alone. Survey-weighted analyses were used to generate national estimates. A p-value < 0.05 was considered statistically significant.

Results: A total of 1880 adult IBD-A hospitalization events were included. The top reasons for hospitalizations for IBD-A patients were: Ulcerative colitis (12.2%), followed by sepsis (10.6%), and then Crohn’s disease with and without complications (6.0%). Compared with IBD patients without arthritis, patients with IBD-A were more likely to be younger (median age 42 vs 55 years, p value < 0.001) and females (64.1% versus 56.2%, p value 0.002), more frequently had private insurance (48.1% vs 35.9%, p value < 0.001) or Medicaid (21.3% vs 14.7%, p value < 0.001), and less commonly were from lowest quartile of household income [$1 - 55,999] (16.2 % vs 24.1%, p value < 0.001). Geographically, compared to IBD-only patients, IBD-A admissions were more common in the Northeast (28.5% vs 21.5%, p value 0.002) and West (21.7% vs 17.1%, p value 0.046) and less frequent in the South (22.3% vs 36.7%, p value < 0.001). Compared to IBD admissions, IBD-associated arthritis admissions had a similar length of stay, total hospital charges, and in-hospital mortality (1.1% vs 1.6%) as shown in Table 1.

Conclusion: Hospitalizations with IBD-A were more prevalent in younger people and females. There were no differences in race/ethnicity, length of stay, or total hospital charges between the two groups of patients. Future studies should investigate the causes of admissions in patients who are younger and female, and explore if they are sub-optimally treated for their IBD or arthritis, leading to more hospitalizations.

Supporting image 1Table 1. Weighted Descriptive Characteristics of IBD-associated Arthritis (IBD-A) Hospitalizations from the 2016-2020 National Inpatient Sample (n=1880)


Disclosures: F. Sami: None; M. Danila: Boehringer-Ingelheim, 2, Pfizer, 5; L. Caplan: None; R. Sen: None.

To cite this abstract in AMA style:

Sami F, Danila M, Caplan L, Sen R. Sociodemographic Characteristics and Healthcare Utilization in Patients with IBD-Associated Arthritis vs. IBD Alone: A Nationwide Inpatient Analysis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/sociodemographic-characteristics-and-healthcare-utilization-in-patients-with-ibd-associated-arthritis-vs-ibd-alone-a-nationwide-inpatient-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sociodemographic-characteristics-and-healthcare-utilization-in-patients-with-ibd-associated-arthritis-vs-ibd-alone-a-nationwide-inpatient-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology